UNIGE document Scientific Article - Review
previous document  unige:43108  next document
add to browser collection

Traitement de la pyélonéphrite chez l'enfant en 2007

Cachat, François
Zeier, Gregory
Von Vigier, Rodo
Konrad, Martin
Rudin, Christoph
Neuhaus, Thomas
Published in Revue médicale suisse. 2007, vol. 3, no. 100, p. 510-2,514
Abstract Four studies, including two being published as an abstract, have recently demonstrated the feasibility of oral treatment of pyelonephritis in children, with no increased risk of treatment failure, early urinary tract re-infection, or renal scars. To do so, the pediatrician must ensure that: (1) the patient does not appear toxic, has no vomiting; (2) there is no known severe obstructive or refluxing uropathy and (3) parents are deemed to be adherent to the treatment. If these criteria are fulfilled, the pediatrician can start an oral treatment with a 3rd generation cephalosporine for 10 to 14 days. Ambulatory follow-up is crucial, and persistance of fever after 3 days is a reason for a new outpatient visit, additional or supplementary imaging studies (renal ultrasonography) and eventually a switch to intravenous treatment.
Keywords Administration, OralChildHumansInjections, IntravenousPyelonephritis/drug therapy
PMID: 17410936
Full text
Article (Published version) (52 Kb) - document accessible for UNIGE members only Limited access to UNIGE
Article (Published version) (1.8 MB) - document accessible for UNIGE members only Limited access to UNIGE
Other version: http://www.revmed.ch/rms/2007/RMS-100/32086
Research group Pathogénèse du syndrome néphrotique idiopathique de l'enfant (180)
(ISO format)
CACHAT, François et al. Traitement de la pyélonéphrite chez l'enfant en 2007. In: Revue médicale suisse, 2007, vol. 3, n° 100, p. 510-2,514. https://archive-ouverte.unige.ch/unige:43108

242 hits



Deposited on : 2014-12-11

Export document
Format :
Citation style :